Chemotherapy of advanced non small cell lung cancer (NSCLC) without driver mutations is mainly platinum - based chemotherapy, the current regimens achieve nearly the same effectiveness with 4 - 6 cycle of chemotherapy; pemetrexed with less toxicity, so after 4 - 6 cycles of platinum - based induction chemotherapy it can be maintained until intolerant side - effects or progessive disease.